DCGI has given approval for Bharat Biotech’s Covid Nasal vaccine.

Share news

Union Health Minister Dr. Man Sukh Mandavya said on Tuesday (September 06) that the DCGI has given approval for limited emergency use of Bharat Biotech’s Covid Nasal vaccine.

It is India’s first nasal covid vaccine. The report stated that the DCGI (Drugs Controller General of India) has given permission for use of Hyderabad-based Bharat Biotech’s nasal vaccine for restricted emergency use to people above 18 years of age.

The report said that by allowing the use of the covid nasal vaccine, the fight against covid-19 infection in the country will be strengthened.

Hyderabad-based Bharat Biotech has conducted a clinical trial of the nasal vaccine on nearly 4,000 volunteers and no side effects have been found, company sources said.

Share news

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button